IC
REVS icon

Inscription Capital’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Inscription Capital’s Portfolio REVS Stock Details REVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Buy
39,136
+21,271
+119% +$655K 0.11% 176
2026
Q1 		$511K Buy
+17,865
New +$521K 0.05% 357

Other funds holding REVS

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FIB
First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
RA
Ruggaard & Associates Hudson, Ohio $279M AUM 18.61% 1-Year Est. Return

Inscription Capital's REVS Position: Q2 2026 in Review

Inscription Capital increased its Columbia Research Enhanced Value ETF (REVS) stake by 119% in Q2 2026, buying an estimated $655K and bringing the position to 39,136 shares worth $1.23M. The position accounts for 0.11% of the portfolio, ranked #176.

Inscription Capital first reported a position in REVS in Q1 2026 and has held it in 2 quarters since. 38 funds tracked by Wall St. Rank hold REVS as of Q2 2026.

  • Inscription Capital held 39,136 shares of Columbia Research Enhanced Value ETF worth $1.23M as of Q2 2026.
  • Inscription Capital bought 21,271 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $655K.
  • Columbia Research Enhanced Value ETF made up 0.11% of Inscription Capital's portfolio in Q2 2026, its #176 holding.
  • Inscription Capital first reported a position in Columbia Research Enhanced Value ETF in Q1 2026 and has held it in 2 quarters since.
  • 38 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.